Genmab AS (Denmark) Price on March 1, 2024

GMAB Stock  DKK 1,526  15.00  0.99%   
If you're considering investing in Genmab Stock, it is important to understand the factors that can impact its price. As of today, the current price of Genmab AS stands at 1,526, as last reported on the 1st of December, with the highest price reaching 1,532 and the lowest price hitting 1,504 during the day. Genmab AS holds Efficiency (Sharpe) Ratio of -0.2, which attests that the entity had a -0.2% return per unit of risk over the last 3 months. Genmab AS exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Genmab AS's Risk Adjusted Performance of (0.15), market risk adjusted performance of (0.47), and Standard Deviation of 1.5 to validate the risk estimate we provide.
  
Genmab Stock price history is provided at the adjusted basis, taking into account all of the recent filings.

Sharpe Ratio = -0.1976

Best PortfolioBest Equity
Good Returns
Average Returns
Small Returns
CashSmall RiskAverage RiskHigh RiskHuge Risk
Negative ReturnsGMAB

Estimated Market Risk

 1.5
  actual daily
13
87% of assets are more volatile

Expected Return

 -0.3
  actual daily
0
Most of other assets have higher returns

Risk-Adjusted Return

 -0.2
  actual daily
0
Most of other assets perform better
Based on monthly moving average Genmab AS is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Genmab AS by adding Genmab AS to a well-diversified portfolio.

Genmab AS Valuation on March 1, 2024

It is possible to determine the worth of Genmab AS on a given historical date. On March 1, 2024 Genmab was worth 1920.5 at the beginning of the trading date compared to the closed value of 2017.0. We use multiple weighted factors in our valuation methodologies to arrive at the intrinsic value of Genmab AS stock. Still, in general, we apply an absolute valuation method to find Genmab AS's value based on its fundamental and technical indicators available within our service. As compared to an absolute model, our relative valuation model uses a comparative analysis of Genmab AS where we calculate exposure to its market risk and evaluate relevant financial multiples and ratios against Genmab AS's related companies.
 Open High Low Close Volume
  1,910    1,948    1,896    1,930    234,124  
03/01/2024
  1,920    2,017    1,918    2,017    145,540  
  2,018    2,039    1,948    1,954    119,207  
Backtest Genmab AS  |  Genmab AS History  |  Genmab AS Valuation   PreviousNext  
Open Value
1920.5
2017.0
Closing Value
1,925
Upside

Genmab AS Trading Date Momentum on March 1, 2024

On March 04 2024 Genmab AS was traded for  1,954  at the closing time. The highest price during the trading period was 2,039  and the lowest recorded bid was listed for  1,948 . The volume for the day was 119.2 K. This history from March 4, 2024 contributed to the next trading day price decline. The overall trading delta to the next closing price was 3.12% . The overall trading delta to the current price is 1.64% .

Genmab AS Fundamentals Correlations and Trends

By evaluating Genmab AS's financials over time, investors can gain insight into future company performance. However, you can also analyze the published financial statements to find patterns among Genmab AS's main balance sheet or income statement drivers and many other relevant indicators that can statistically be found significantly correlated or uncorrelated. Genmab financial account trend analysis is a perfect complement when working with valuation or volatility modules.

About Genmab AS Stock history

Genmab AS investors dedicate a lot of time and effort to gaining insight into how a market's past behavior relates to its future. Access to timely market data for Genmab is vital when making an investment decision, and regardless of whether you use fundamental or technical analysis, your return on investment in Genmab AS will depend on recognizing future opportunities and eliminating past mistakes. Historical data analysis is the study of market behavior over a given time. Recorded market-related data such as price, volatility, and volume can be quantified and studied over a defined period. Through a detailed examination of a market's past behavior, traders and investors can gain perspective on the inner workings of that market. The information obtained throughout analyzing Genmab AS stock prices may prove useful in developing a viable investing in Genmab AS
Genmab AS develops antibody therapeutics for the treatment of cancer and other diseases primarily in Denmark. Genmab AS was founded in 1999 and is headquartered in Copenhagen, Denmark. Genmab AS is traded on Copenhagen Stock Exchange in Denmark.

Genmab AS Stock Technical Analysis

Genmab AS technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Genmab AS technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Genmab AS trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...

Price Boundaries

Genmab AS Period Price Range

Low
December 1, 2024
0.00  NaN%
High

 0.00 

     

 0.00 

Genmab AS cannot be verified against its exchange. Please verify the symbol is currently traded on Copenhagen Exchange. If you still believe the symbol you are trying to look up is valid, please let us know, and we will check it as soon as possible.

Genmab AS December 1, 2024 Market Strength

Market strength indicators help investors to evaluate how Genmab AS stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Genmab AS shares will generate the highest return on investment. By undertsting and applying Genmab AS stock market strength indicators, traders can identify Genmab AS entry and exit signals to maximize returns

Genmab AS Technical and Predictive Indicators

Predictive indicators are helping investors to find signals for Genmab AS's price direction in advance. Along with the technical and fundamental analysis of Genmab Stock historical price patterns, it is also worthwhile for investors to track various predictive indicators of Genmab to make sure they correctly time the market and exploit it's hidden potentials. Even though most predictive indicators are useful for the short-term horizon, it's virtually impossible to predict the unforeseen market. For traders with a short-term horizon, predictive indicators add value when properly applied. Long-term investors, however, may find many predictive indicators less useful.

Additional Information and Resources on Investing in Genmab Stock

When determining whether Genmab AS offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Genmab AS's financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Genmab As Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Genmab As Stock:
Check out Risk vs Return Analysis to better understand how to build diversified portfolios, which includes a position in Genmab AS. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in board of governors.
To learn how to invest in Genmab Stock, please use our How to Invest in Genmab AS guide.
You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Please note, there is a significant difference between Genmab AS's value and its price as these two are different measures arrived at by different means. Investors typically determine if Genmab AS is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Genmab AS's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.